Latest Breaking News On - எதிர்கால ஒன்றாக - Page 8 : comparemela.com

Lykan Bioscience Welcomes Kenneth LeClair as Chief Technology Officer News provided by Share this article Share this article HOPKINTON, Mass., April 13, 2021 /PRNewswire/  Lykan Bioscience, a contract development and manufacturing services organization and provider of the first true end-to-end solution for the manufacture of cell-based therapies, welcomes Kenneth LeClair as Chief Technology Officer. Ken joins the executive leadership team and will be responsible for leading the company s Manufacturing Science and Technology and Process Development teams. Ken brings over 40 years of academic and industry experience to the Lykan team.  Prior to Lykan, Ken was VP of Technical Development and Manufacturing at TScan Therapeutics and Editas Medicine. Before that, he spent 8 years at Novartis, transitioning biologic candidates from research into clinical development.  Ken was also responsible for the early technical diligence and supply chain development for the CAR-T product, Kymr

Kenneth leclairOkim yangLykan biosciencePatrick lucyFuture togetherகெநெத் லெக்லர்கிம் யாங்பேட்ரிக் லூசிஎதிர்கால ஒன்றாக